Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to -$11.4 million.

  • Healthequity's Cash from Investing Activities rose 1153.52% to -$11.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$52.3 million, marking a year-over-year increase of 8961.36%. This contributed to the annual value of -$505.5 million for FY2025, which is 99704.82% down from last year.
  • Latest data reveals that Healthequity reported Cash from Investing Activities of -$11.4 million as of Q4 2025, which was up 1153.52% from -$11.2 million recorded in Q3 2025.
  • Healthequity's Cash from Investing Activities' 5-year high stood at -$9.1 million during Q2 2023, with a 5-year trough of -$471.3 million in Q1 2022.
  • In the last 5 years, Healthequity's Cash from Investing Activities had a median value of -$15.8 million in 2023 and averaged -$68.4 million.
  • As far as peak fluctuations go, Healthequity's Cash from Investing Activities soared by 9781.97% in 2023, and later plummeted by 285511.77% in 2024.
  • Over the past 5 years, Healthequity's Cash from Investing Activities (Quarter) stood at -$79.7 million in 2021, then soared by 83.02% to -$13.5 million in 2022, then fell by 13.99% to -$15.4 million in 2023, then increased by 16.57% to -$12.9 million in 2024, then rose by 11.54% to -$11.4 million in 2025.
  • Its Cash from Investing Activities was -$11.4 million in Q4 2025, compared to -$11.2 million in Q3 2025 and -$16.1 million in Q2 2025.